Professional career
Curriculum vitae
Since 2021
Head Physician Oncology/Haematology
2017-2020
Senior Physician Medical Oncology
St. Claraspital Basel
2017
Specialist title FMH Medical Oncology
2016
Clinical Research Fellow, medical oncology, renal, melanoma and gynae unit
Royal Marsden Hospital, London, UK
2015
Senior consultant in medical oncology
St. Claraspital Basel
2014-2015
Assistant doctor in medical oncology
St. Claraspital Basel
Memberships and commitments
List of memberships
Swiss Federal Medical Association (FMH)
European Society of Medical Oncology (ESMO)
Swiss Society of Medical Oncology (SGMO)
Publications
- Schmid T, Templeton A: Modern therapy of advanced prostate carcinoma. 2021: Swiss Journal of Oncology SZO 1: 10-18.
- Templeton AJ, Schmid T. When information is censored. Info@Oncology. 2020; 6: 28-30.
- Schmid T, Templeton AJ. When my patient is not a trial patient: Efficacy-Effectiveness Gap. Info@Oncology. 2020; 04: 23-24
- Aviv Ladanie, Andreas M. Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago V. Pereira, Francesco Sclafani, Amanda K. Herbrand, Matthias Briel, Juan Martin-Liberal, Thomas Schmid, Hannah Ewald, John P. A. Ioannidis, Heiner C. Bucher, Benjamin Kasenda, and Lars G. Hemkens Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016. JAMA Netw Open. 2020 Nov; 3(11): e2024406.
- Gasser O, Schmid T, Zenhaeusern G, Hess C: Cyclooxygenase Regulates Cell Surface Expression of CXCR3/1-Storing Granules in Human CD4+ T Cells. J. Immunol. 2006; 177: 8806-8812.
- Egli A, Khanna N, Schmid T, Rudin S, Frei R, Blaich A.: Recurrent fever after a holiday in Turkey. BMJ. 2011; 343:d7832.
- Schmid T, Rothschild S, Zimmermann F, Papachristofilou A.: Tumours of the lung, epidemiology, aetiology, pathology, diagnosis and follow-up. Info Oncology 2011; 14 (6): 33-42
- Schmid T, Rothschild S, Zimmermann F, Papachristofilou A.: Tumours of the lung, therapeutic strategies for SCLC and NSCLC. Info Oncology 2011; 14 (8): 24-34
- Schmid T, Papachristofilou A, Zimmermann F.: Modern radiotherapeutic concept - stereotactic, adjuvant, palliative [Article in German]. Ther Umsch. 2012; 7:420-8.
- Schmid T, Conen K, Mosna-Firlejczyk K, Groß M, Zimmermann F.: Bone metastases: Clinical picture, diagnostics and therapy. Info Oncology 2013; 6: 31-38
- Schmid T, Köberle D, Buess M.: Year-old patient with EGFR mutated metastatic adenocarcinoma of the lung - excellent clinical benefit from therapy with erlotinib Poster Annual Meeting of the DGHO, OeGHO, SGMO and SGH 2016; 85
- Vetter M, Fokas S, Biskup E, Schmid T, Schwab F, Schoetzau A, Gueth U,
- Rochlitz C, Zanetti-Daellenbach R: Addition of carboplatin to standard chemotherapy is not beneficial in the adjuvant treatment of unselected triple negative breast cancers (TNBC). Poster ASCO Annual Meeting 2016;
- Theurich S, Rothschild S, Hoffmann M, Fabri M, Sommer A, Garcia-Marquez M, Thelen M, Schill C, Merki R, Schmid T, Koeberle D, Zippelius A, Baues C, Mauch C, Tigges C, Kreuter A, Borggrefe J, von Bergwelt-Baildon M, Schlaak M.: Local Tumour Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma Cancer Immunol Res. 2016 Sep 2;4(9):744-54.
- Schmid T, Gore M.: Sunitinib in the treatment of metastatic renal cell carcinoma. Ther Adv Urol. 2016 Dec;8(6):348-371
- Vetter M, Fokas S, Biskup E, Schmid T, Schwab F, Schoetzau A, Güth U, Rochlitz C, Zanetti-Dällenbach R.
- Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single centre experience. Oncotarget. 2017 May 23;8(43):75617-75626.
- Spain L, Walls G, Julve M, O'Meara K, Schmid T, Kalaitzaki E, Turajilic S, Gore M, Rees J, Larkin J: Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Ann Oncol 2017 28 (2): 377-385.
- Spain L, Schmid T, Gore M, Larkin J.: Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features. Eur J Cancer. 2017 Apr;75:243-244
- M. Morone, L. Spain, J. Winfield, T. Schmid, D.-M. Koh, D. Collins, A. Sohaib, J. Larkin, M. Bali: Comparison of imaging response criteria in metastatic melanoma patients treated with immune checkpoint inhibitors: a single institution analysis" ECR oral abstract presentation 2017
- Schmid T, Templeton A.: Renal cell carcinoma - current treatment options. Onco Mag - The Swiss Oncology Magazine (2017); 3: 20-3
- Ladanie A, Speich B, Naudet F, Agarwal A, Pereira TV, Sclafani F, Martin-Liberal J, Schmid T, Ewald H, Ioannidis JPA, Bucher HC, Kasenda B, Hemkens LG: The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials. 2018 Sep 19;19(1):505.
- T. Schmid, and M. Buess: Overcoming resistance in a BRAF V600E-mutant adenocarcinoma of the lung. Curr Oncol. 2018 Jun; 25(3): e217-e219
- Schmid T, Templeton AJ. Highlights from ASCO on metastatic prostate cancer. Leading Opinions Haematology & Oncology 2018; 5: 20-23.